The role of streptococcal hypersensitivity in the pathogenesis of Behçet's disease

European Journal of Dermatology

Volumn 18, Issue 5, 2008, Pages 489-498

  Kaneko, Fumio ^a   Oyama, Noritaka ^a   Yanagihori, Hirokatsu ^b   Isogai, Emiko ^c   Yokota, Kenji ^d   Oguma, Keiji ^d  

^a Southern Tohoku General Hospital and Southern Tohoku Research Institute for Neuroscience   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^d OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Beh et's disease; Bes 1 gene; Heat shock protein; Streptococcus sanguinis; Vascular reaction

Indexed keywords

FICOLIN; FICOLIN 1; FICOLIN 2; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 65; HLA A ANTIGEN; HLA B51 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 8; MANNOSE BINDING LECTIN; TRANSCRIPTION FACTOR POU4F2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN FUNCTION; BACTERIUM ISOLATION; BEHCET DISEASE; CD8+ T LYMPHOCYTE; COMPLEMENT SYSTEM; GENE EXPRESSION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MOUTH FLORA; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; REVIEW; RISK FACTOR; SKIN TEST; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SANGUINIS; UVEITIS;

BEHCET SYNDROME; CHAPERONIN 60; HEAT-SHOCK PROTEINS; HUMANS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SANGUIS;

EID: 52649127924     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0484     Document Type: Review

References (86)

1. Behcet H. Uber rezidivierende, aphthous durch ein Virus verursachte Geschwuere am Mund, am Auge und an den Genitalien. Dermatol Wochenschri 1937; 105: 1152-7.
2. Adamantiades B. Sur un cas d'iritis a hypopion recidivant. Ann Ocul (Paris) 1931; 168: 271-8.
3. Altenburg A, Papoutsis N, Orawa H, Martus P, Krause L, Zouboulis CC. Epidemiology and clinical manifestations of Adamantiades-Behcet's disease in Germany- Current pathogenic concepts and therapeutic possibilities. J Dtsch Dermatol Ges 2006; 4: 49-64.
4. Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet's disease. Yonsei Med J 2007; 48: 573-85.
5. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behcet's disease. Arch Ophthalmol 1982; 100: 1455-8.
6. Zouboulis CC, May T. Pathogenesis of Adamantiades-Behcet's disease. Med Microbiol Immunol (Berl) 2003; 192: 149-55.
7. Karaycian A, Zouboulis CC. An update on Behcet's disease. J Eur Acad Dermat-Venereol 2007; 21: 1-10.
8. Krause I, Weinberger A. Behcet's disease. Current Opin Rheum 2008; 20: 82-7.
9. Kaneko F, Kaneda T, Ohnishi O, Kishiyama K, Takashima I, Fukudo H, Kado Y. Infection allergy in Behcet's disease (1). Jpn J Allergol 1978; 27: 440-50.
10. Kaneko F, Oyama N, Nishibu A. Streptococcal infection in the pathogenesis of Behcet's disese and clinical effects of minocycline on the disease symptoms. Yonsei Med J 1997; 38: 444-54.
11. Yokota K, Hayashi S, Araki Y, Isogai E, Kotake S, Yoshikawa K, Fujii N, Hirai Y, Oguma K. Characterization of Streptococcus sanguis isolated from patients with Behcet's disease. Microbiol Immunol 1995; 39: 729-32.
12. Isogai E, Ohno S, Takashi K, Yoshikawa K, Turumizu T, Isogai H, Yokota Y, Hashimoto T, Shimizu H, Matsuda H, Fujii N, Yamaguchi M, Oguma K. Close association of Streptococcus sanguis uncommon serotypes with Behcet's disease. Bifidobacteria Microflora 1990; 9: 27-41.
13. Isogai E, Ohno S, Kotake S, Isogai E, Tsurumizu T, Fujii N, Syuto B, Yamaguchi M, Matsuda H, Oguma K. Chemiluminescence of neutrophils from patients with Behcet's disease and its correlation with an increased proportion of uncommon selotypes of Streptococcus sanguis in the oral flora. Arch Oral Biol 1990; 35: 43-8.
14. Graykowski EA, Baril MF, Boyd LM, Stanley HR. Recurrent aphthous stomatitis: Clinical therapeutic and histopothologic and hypersensitivity aspects. JAMA 1966; 196: 637-44.
15. Kaneko F, Takahashi Y, Muramatsu Y, Miura Y. Immunological studies on aphthous ulcer and erythema nodosum-like eruptions in Behcet's disease. Br J Dermatol 1985; 113: 303-12.
16. Mizushima Y, Matsuda T, Hoshi K, Ohno S. Induction of Behcet's disease symptoms after dental and streptococcal antigen skin test. J Rheum 1988; 15: 1029-30.
17. Hirohata S, Oka H, Mizushima Y. Streptococcal antigens stimulate production of IL-6 and interferon-γ by cells from patients with Behcet's disease. Cell Immunol 1992; 140: 410-9.
18. Yokota K, Hayashi S, Fujii N, Yoshikawa K, Kotake S, Isogai E, Ohono S, Araki Y, Oguma K. Antibody response to oral streptococci in Behcet's disease. Microbiol Immunol 1992; 36: 815-22.
19. Lehner T. The role of heat shock protein, microbial and autoimmune agents in the etiology of Behcet's disease. Intern Rev Immunol 1997; 14: 21-32.
20. Kaneko S, Suzuki N, Yamashita N, Nagafuchi H, Nakajima T, Wakisaka S, Yamamoto S, Sakane T. Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan. Clin Exp Immunol 1997; 108: 204-12.
21. Kibaroglu A, Eksioglu-Demiralp E, Akoglu T, Direskeneli H. T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behcet's disease. Clin Exp Rheumatol 2004; 22(Suppl, 34): S59-S63.
22. Sakane T, Takeno M, Suzuki N, Inaba G. Current concepts: Behcet's disease. N Engl J Med 1999; 341: 1284-91.
23. Suzuki-Krokawa M, Suzuki N. Behcet's disease. Clin Exp Med 2004; 3: 10-20.
24. Takeno M, Kariyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, Sakane T. Excessive function at peripheral blood neutrophils from patients with Behcet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995; 38: 426-33.
25. Mizuki N, Inoko H, Ohno S. In: Lee S, Bang D, Lee E-S Sohn S, eds. Molecular genetics (HLA) of Behcet's disease. Behcet's Disease A guide to its Clinical Understanding. Springer, 2001: 87-100.
26. Liblau RS, Wong FS, Mars J, Santamaria P. Autoreactive CD8 T cells in organ-specific autoimmunity; emerging targets for therapeutic intervention. Immunity 2002; 17: 1-6.
27. Yasuoka H, Okazaki Y, Kawakami Y, Hirakata M, Inoko, H, Kuwana M. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behcet's disease. Arthritis Rheum 2004; 50: 3658-62.
28. Mizuki N, Ota M, Kimura M, Ohno S, Ando H, Katsuyama Y, Yamazaki M, Watanabe K, Goto K, Nakamura S, Bahram S, Inoko H. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet's disease. Proc Natl Acad Sci USA 1997; 94: 1298-303.
29. Zierhut M, Mizuki N, Ohno S, et al. Immunology and functional genomics of Behcet's disease. Cell Mol Life Sci 2003; 60: 1903-22.
30. Pay S, Simsek I, Erden H, Dinc A. Immunopathogenesis of Behcet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 2006; 14: 1-14.
31. Seo J, Park JS, Nam JH, Bang D, Shon S, Lee ES, Park KS. Association of CD94/NKG2A, CD94/NKG2C and its ligand HLA-E polymorphisms with Behcet's disease. Tissue Antigens 2007; 70: 307-13.
32. Kaneko F, Takahashi Y, Muramatsu R, Minagawa T. Natural killer cell numbers and function in peripheral lymphoid cells in Behcet's disease. Br J Dermatol 1985; 113: 313-8.
33. Yanagihori H, Oyama N, Nakamura K, Mizuki N, Oguma K, Kaneko F. Role of IL-12B promoter polymorphisum in Adamantiades-Behcet's disease susceptibility: An involvement of Th1 immmunoreactivity against Streptococcus sanguinis antigen. J Invest Dermatol 2006; 126: 1534-40.
34. Mumcu G, Inanc N, Ergan T, Ikiz K, Gunes M. islek U, Yovuz S, Sur H, Atalay T, Direskeneli H. Oral health is impaired in Behcet's disease and is associated with disease activity. Rheumatol 2004; 43: 1028-33; (Oxford).
35. Isogai E, Isogai H, Kotake S, Ohno Ishihora M, Aeki K, Tojo M, Kaneko F, Yokota K, Oguma K. Antibody cross reactivity from sera of patients with Behcet's disease with synthetic peptides that have homologies with protein from Streptococcus sanguis. J Appl Res 2002; 2: 1-7.
36. Isogai E, Isogai H, Kotake S, Ohno S, IKimura K, Oguma K. Role of Streptococcus sanguis and traumatic factors in Behcet's disease. J Appl Res 2003; 3: 64-75.
37. Yoshikawa K, Kotake S, Kubota T, Kimura K, Isogai E, Fujii N. Cloning and sequencing of BES-1 gene encoding the immunogenic antigen of Streptococcus sanguis KTH-1 isolated from patients with Behcet's disease. Zent bl Bakteriol 1998; 287: 449-60.
38. Tojo M, Yanagihori H, Zheng X, Oyama N, Isogai E, Kimura K, Nakamura K, Kaneko F. Bes-1 DNA fragment encoding Streptococcal antigen in skin lesions from patients with Behcet's disease. J Apl Res 2003; 3: 232-8.
39. Tojo M, Zheng X, Yanagihori H, Oyama N, Takahashi K, Nakamura K, Kaneko F. Detection of herpes virus genomes in skin lesions from patients with Behcet's disease and other related inflammatory disease. Acta Derm Venereal 2003; 83: 1-4.
40. Sohn S, Lee ES, Bang D, Lee S. Behcet's disease-like symptoms induced by the herpes simplex virus in ICR mice. Eur J Dermatol 1998; 8: 21-3.
41. Xiang M, Zhou L, Peng Y. Eddy RI, Shows TB, Nathans J. Brn 3b: POU domain gene expressed in a subset of retinal ganglion cells. Neuron 1993; 11: 689-701.
42. Kulaber A, Tugal-Turkan I, Yentur SP, Akman-Demir G, Kaneko F, Gul A, Saruhan-Direskeneli G. Proinflammatory cellular immune response in Behcet's disease. Rheumatol Int 2007; 27: 111-8.
43. Jindal S, Dudani AK, Singh B, Harley CB, Gupta RS. Primary structure of a human mitochondrial protein homologous to the bacterial and plant chaperonims and to the 65-kilodalton mycobacterial antigen. Mol Cell Biol 1989; 9: 2279-83.
44. Lamb JR, Young DB. T cell recognition of stress proteins: a link between infections and autoimmune disease. Mol Biol Med 1990; 7: 311-21.
45. Lehner T, Lavery E, Smith R, van der Zee R, Mizushima Y, Shinnick T. Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behcet's syndrome. Infect Immun 1991; 59: 1434-41.
46. Pervin K, Chlderstone A, Shinnick T, Mizushima Y, van der Zee R, Hasan A, Vaughan R, Lehner T. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behcet's disease. J Immunol 1993; 151: 2273-82.
47. Poccia F, Pielli P, Vendetti S, Back S, Amendola A, Placido R, Celizzi V. Heat shock protein expression on the membrane of T cells undergoing apoptosis. Immunol 1996; 88: 6-12.
48. Ergun T, Ince U, Eksioglu-Demiralp E, Direskeneli H, Gurbuz O, Gurses L, Aker F, Akoglu T. HSP60 expression in mucocutaneous lesions of Behcet's disease. J Am Acad Dermatol 2001; 45: 904-9.
49. Direskeneli H, Ekisiogu-Demiralp E, Yavuz S, Ergan T, Shinnick T, Lehner T, Akogl T. T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behcet's disease. J Rheumato 2000; 27: 708-13.
50. Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C, Tsukikawa S, Ozaki S, Matsuda T, Suzuki N. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of internal Behcet's disease. Clin Exp Immunol 2005; 139: 371-8.
51. Suzuki N, Sakane T. Characterisation of heat shock protein specific T cells in patients with Behcet's disease. Rev Rheum 1996; 63: 531-63.
52. Direskeneli H, Saruhan-Direskeneli G. The role of heat shock proteins in Behcet's disease. Clin Exp Rheumatol 2003; 21 (Suppl. 30): S44-S48.
53. Shaker O, Ay El-Deen MA, El Hadid H, Grace BID, ElSherif H, Adbel Haim A. The role of heat shock protein 60, vascular endothelial factor and antiphospholipid antibodies in Behcet's disease. Br J Dermatol 2007; 156: 32-7.
54. Jorrizzo JL, Abernothy JL, White WL, Mongelsdorf HC, Zouboulis CC, Sarica R, Gaffney K, Mat C, Yazici H, Al Lalaan A, Assad-Kahalil SH, Kaneko F, Jorizzo EAF. Mucocutaneous criteria for the diagnosis of Behcet's disease: an analysis of clinicopathologic data from multiple international centers. J Am Acad Dermatol 1995; 32: 968-76.
55. Yi SW, Kim EH, Kang HY, Kim YC, Lee ES. Erythema nodosum: clinicopathologic correlations and their use in differential diagnosis. Yonsei Med J 2007; 48: 601-8.
56. Iikunur T, Pabuccuoglu U, Akin C, Lebe B, Gunes AT. Histopathologic and direct immunofluorescence findings of the papulopustular lesions in Behcet's disescise. Eur J Dermatol 2006; 16: 146-50.
57. Ates A, Tiryaki OA, Olmez U, Tukkak H. Serum-soluble selectin levels in patients with Behcet's disease. Clin Rheumatol 2007; 26: 411-7.
58. Lee MT, Hooper LC, Kump L, Hayashi K, Nussenblatt R, Hooks JJ, Detrick B. Interferon-beta and adhesion molecules (E-selectin and s-intercellular adhesion molecule-1) and detected in sera from patients with retinal vasculitis and are induced in retinal vascular endothelial cells by Toll-like receptor 3 signalling. Clin Exp Immunol 2007; 147: 71-80.
59. Yalcin B, Arda N, Tezel GG, et al. Expression of vascular endothelial growth factor and CD34 in oral aphthous lesions of Behcet's disease. Anal Quant Cytol Histol 2006; 28: 303-6.
60. Hu W, Hason A, Wilson A, Stanford MR, Li-Yang Y, Todryk S, Whiston R, Shinneck T. van der Zee, Lehner T. Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol 1998; 28: 2444-55.
61. Phipps PA, Stanford MR, Sun JB, Xiao BG, Holmgren J, Shinnick T, Hasan A, Mizushima Y, Lehner T. Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit. Eur J Immunol 2003; 33: 224-32.
62. Stanford M, Whittal T, Bergemeier LA, Lindbald M, Lundin S, Shinnick T, Mizushima Y, Holmgren J, Lehner T. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Cln Exp Immunol 2004; 137: 201-8.
63. Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican SH. pylori infection in patients with Behcet's disease. World J Gastroentrol 2007; 7: 2985.
64. Apan TZ, Gursel R, Dolgun A. Increased eropositivity of Helicobactor pylori cytotoxi-associated gene A in Behcet's disease. Clin Rheumatol 2007; 26: 88-9.
65. Zouboulis CC, Turnbull JR, Muhlradt F. High seroprevarence of anti-mycoplasma fermentans antibodies in patients with malignant aphthosis. J Invest Dermatol 2003; 121: 211-2.
66. Chen ZW, Letvin NL. Adaptive immune response fVγ2Vδ2 cells: A new paradign. Trends Immunol 2003; 24: 213-9.
67. Bank I, Duvelevani M, Livneh A. Expansion Of γδ T-cells in Behcet's disease: Role of disease activity and microbial flora in oral ulcers. J Lab Clin Med 2003; 141: 33-41.
68. Radiuddin S, Al-Dalaan A, Bahabri 5, Siraj AK, Al-Sedairy S. Divergent cytokine production profile in Behcet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol 1998; 25: 329-33.
69. Hamzaoui K, Hamzaoui A, Ghorbel I, Khanfir M, Houman H. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behcet's disease. Scand J Immunol 2006; 64: 655-60.
70. Lew W, Chang JY, Jung TY, Bang D. Increased expression of interleukin-23 p19mRNA in erythema nodosum-like lesion of Behcet's disease. Br J Dermatol 2008; 158: 505-11.
71. Zugel U, Kaufman HE. Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 1999; 12: 19-39.
72. Oguma K, Shin R, Yokota K. Studies on immunological responses by bacterial antigens in Behcet's disease. Report of the Research Group for Behcet's Disesae organized by the Japanese Ministry of Health. Labour and Welfare 2008; 2006-2007: 31-3; (in Japanese).
73. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002; 168: 554-61.
74. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T, Endres S, Hartmann G. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168: 4531-7.
75. Suzuki N, Kurokawa M, Nara K, Yoshikawa H, Nonaka N, Matsuda T, Ikeshima H, Kaneko S, Morita S. A study for abnormal immunity and inflammation in lesions of Behcet's disesase. Report of the Research Group for Behcet's Disease organized by Japanese Ministry of Health, Labour and Welfare, 2007, 35-9 (in Japanese).
76. Yavus S, Elbir Y, Tulunay A, Eksioglu-Demirap E, Direskeneli H. Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet's disease etiopathogenesis. Rheumatol Int 2007; (DOI 10.1007/ s00296-007-0470-y).
77. Durranni O, Wallace GR, Hamburger J, et al. Toll-like receptors (TLRs) expression in oral ulcer biopsies from Behcet's disease (BD) patients: a role for the innate immune syste in BD. Clin Exp Rheumatol 2004; 22(Suppl. 3A): S-93.
78. Medzhitov R, Janeway CA. Innate immunity. N Engl J Med 2000; 343: 338-44.
79. Kilpatrick DC. Mannose-binding lectin: clinical significance and applications. Biochin Biophys Acta 2002; 1572: 401-13.
80. Inanc N, Mumcu G, Birtas E, Blsir Y, Yavuz S, Fresko I, Direskeneli H. Serum mannose-binding lectin levels are decreased in Behcet's disease and associated with disease severity. J Rheumatol 2005; 32: 287-91.
81. Matsushita M, Fujita T. The role of ficolins in innate immunity. Immunobiology 2002; 205: 490-7.
82. Lynch NJ, Roscher S, Hartung T, Morath S, Matsushita M, Maennel DN, Kuraya M, Fujita T, Schwaeble WJ. L-ficolin specifically binds to lipoteic acid, a cell wall constituent of Gram-positive bacteria and activates the lectin pathway of complement. J Immunol 2004; 172: 1198-202.
83. Wang H, Nakamura K, Inoue T, Yanagihori H, Kawakami Y, Hashimoto S, Oyama N, Kaneko F, Fujita T, Nishida T, Mizuki N. Mannose-binding lectin polymorphisms in patients with Behcet's disease. J Dermatol Sci 2004; 36: 115-7.
84. Chen X, Katoh Y, Nakamura K, Oyama N, Kaneko F, Endo Y, Fujita T, Nishida T, Mizuki N. Single nucleotide Polymorphisms of Ficolin 2 gene in Behcet's disease. J Dermatol Sci 2006, 43: 201-5.
85. Calguneri M, Ertenli I, Kiraz S, Ertenli I, Benek-Li M, Karaarslan Y, Celik I. Effect of prophylacticbenzathine penicilline on mucocutaneous symptoms of Behcet's. Dermatology 1996; 192: 125-8.
86. Mumcu G, Inac N, Yavuz S, Direskeneli H. The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behcet's disease. Clin Exp Rheumatol 2007; 25: S27-S33.